Article: FDA clears new indication for Abilify.(Otsuka Pharmaceutical Company Ltd. and Bristol-Myers Squibb Co.'s antipsychotic agent)(Brief Article)

Article: Bristol-Myers Squibb and Otsuka ...
PR Newswire;  November 7, 2001 ;     700+ words ... ... these data, Bristol-Myers Squibb and Otsuka Pharmaceutical also expect to file ... About Bristol-Myers Squibb and Otsuka Pharmaceutical Co., Ltd. Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd., are ...

Article: Otsuka Pharmaceutical/Bristol-Myers ...
PR Newswire;  June 16, 2003 ;     700+ words ... ... leading research and advisory firms focusing on pharmaceutical and health care issues, forecasts Otsuka Pharmaceutical/Bristol-Myers Squibb's Abilify will garner 12% of the schizophrenia market in 2012 when it emerges as a first-choice ...

Article: Otsuka licenses domestic rights to B-MS' ...
Pharma Marketletter;  January 8, 2007 ;     587 words ...Japan's Otsuka Pharmaceutical has been granted exclusive domestic rights to develop and commercialize US drug major Bristol-Myers Squibb's investigational compound saxagliptin, for the treatment of type 2 diabetes. Otsuka gains rights to ...

Article: Otsuka Pharmaceutical and Bristol-Myers ...
Medical Marketing & Media;  December 1, 2007 ;     700+ words ...Otsuka Pharmaceutical and Bristol-Myers Squibb announced that the FDA approved the supplemental NDA for the atypical antipsychotic Abilify (aripiprazole) for the treatment ...

Article: Bristol-Myers Squibb and Otsuka ...
PR Newswire;  December 27, 2006 ;     700+ words ... ... FirstCall/ -- Bristol-Myers Squibb Company and Otsuka Pharmaceutical Co., Ltd. today ... About Bristol-Myers Squibb Bristol-Myers Squibb is a global pharmaceutical ... human life. About Otsuka Pharmaceutical Co., Ltd. Founded ...

Article: Abilify wins clearance.(RX: RETAIL PHARMACY: Branded Drugs)(FDA ...
Chain Drug Review;  March 17, 2008 ;     680 words ...The FDA has approved Abilify for the treatment of acute bipolar I disorder in patients between ages 10 and 17. The product is marketed by Otsuka Pharmaceutical Co. and Bristol-Myers Squibb Co.

Article: Bristol-Myers Squibb and Otsuka ...
PR Newswire;  March 5, 2008 ;     700+ words ... ... a new report that finds that Bristol-Myers Squibb and Otsuka Pharmaceutical spend almost twice as much on Abilify ... and fewer than 10% mention Bristol- Myers Squibb or Otsuka Pharmaceutical as a top-of-mind company in atypical ...